HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer
Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor receptor 2 (HER2) that were not present in the original tumor, reports ...
Dec 11, 2018
0
58